Bandari Jathin 4
4 · Protara Therapeutics, Inc. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Bandari Jathin
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-10+13,500→ 13,500 total - Award
Stock Option (Right to Buy)
2022-01-10+81,000→ 81,000 totalExercise: $6.27Exp: 2032-01-09→ Common Stock (81,000 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 10, 2022.
- [F2]25% of the shares vest on the one year anniversary of January 10, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.